CASI Pharmaceuticals
CASI
#10583
Rank
NZ$7.25 M
Marketcap
NZ$0.35
Share price
0.00%
Change (1 day)
-89.39%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.71. In 2024 the company made an earnings per share (EPS) of NZ-$4.36 a decrease over its 2023 EPS that were of NZ-$3.44.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.656.77%
2024NZ-$4.3626.73%
2023NZ-$3.44-32.89%
2022NZ-$5.1211.9%
2021NZ-$4.58-38.44%
2020NZ-$7.44-8.96%
2019NZ-$8.1750%
2018NZ-$5.4577.78%
2017NZ-$3.065.88%
2016NZ-$2.89-22.73%
2015NZ-$3.74-76.09%
2014NZ-$15.65318.18%
2013NZ-$3.74-71.79%
2012NZ-$13.2765.96%
2011NZ-$8.00-50%
2010NZ-$16.00-18.97%
2009NZ-$19.74-63.64%
2008NZ-$54.283.57%
2007NZ-$52.41-60.56%
2006NZ-$132.9097.22%
2005NZ-$67.38-2.7%
2004NZ-$69.26-45.59%
2003NZ-$127.28-61.8%
2002NZ-$333.17-25.52%
2001NZ-$447.35-21.38%
2000NZ-$569.0213.86%
1999NZ-$499.76149.53%
1998NZ-$200.2898.15%
1997NZ-$101.0810.2%
1996NZ-$91.72